Digestive & Intestinal Remedies (Pharmacies) - Moldova

  • Moldova
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$11.53m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.30%, resulting in a market volume of US$12.30m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.46 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Moldova has been experiencing significant development in recent years.

Customer preferences:
Customers in Moldova have shown a growing preference for digestive and intestinal remedies in recent years. This can be attributed to several factors. Firstly, there has been an increasing awareness about the importance of digestive health and its impact on overall well-being. As a result, consumers are seeking out products that can help alleviate digestive issues such as bloating, indigestion, and constipation. Secondly, the busy and stressful lifestyles of modern consumers have led to an increase in digestive problems. This has further fueled the demand for remedies that can provide quick relief. Lastly, the aging population in Moldova has also contributed to the growth of the market, as older individuals are more prone to digestive issues and are more likely to seek remedies to alleviate their symptoms.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Moldova is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives. This trend is in line with the global shift towards natural and organic products. As a result, there has been a rise in the demand for digestive remedies that are made from natural ingredients such as herbs, fruits, and vegetables. These products are perceived to be safer and have fewer side effects compared to their synthetic counterparts. Another trend in the market is the growing availability of digestive remedies in different forms. Traditionally, digestive remedies were available in the form of tablets or capsules. However, there has been an emergence of alternative forms such as powders, liquids, and chewable tablets. This trend caters to the diverse preferences of consumers and provides them with more options to choose from.

Local special circumstances:
Moldova is a small country located in Eastern Europe. It has a relatively low GDP per capita compared to other European countries. This has implications for the Digestive & Intestinal Remedies (Pharmacies) market, as affordability is an important factor for consumers. As a result, there is a demand for cost-effective remedies that provide value for money. Pharmaceutical companies operating in Moldova need to take into consideration the price sensitivity of consumers and offer products at competitive prices.

Underlying macroeconomic factors:
The development of the Digestive & Intestinal Remedies (Pharmacies) market in Moldova is influenced by several macroeconomic factors. Firstly, the country's healthcare system plays a crucial role in shaping the market. The availability of healthcare facilities, the quality of healthcare services, and the level of healthcare expenditure all impact the demand for digestive remedies. Secondly, the overall economic conditions in Moldova, such as GDP growth, inflation rates, and employment levels, also have an impact on consumer spending power and, subsequently, the demand for healthcare products. Lastly, government regulations and policies related to healthcare and pharmaceuticals can also affect the market dynamics.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)